Novel trh receptor
CA 2274305 A1 · Owner: Walker, Philippe · Inventors: Walker, Philippe
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to the novel receptor for TRH which has been designated as THR receptor 2. The invention encompasses both the receptor protein as well as nucleic acids encoding the protein. In addition the , present invention is directed to methods and compositions which rely upon either TRHR-2 proteins or nucleic acids.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 28, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 28, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 28, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.